Close
Digital Health & Ai Innovation summit 2026
APE 2026

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Toshiba America Medical Systems, Inc. has unveiled new cardiac software enhancements available now for the Aquilion® ONE and Aquilion Premium CT systems. The new cardiac CT software package is designed to reduce radiation exposure while maintaining outstanding image quality.

The new software upgrades will improve cardiac CT imaging in the following ways:

  • New ONE Beat Prospective Reconstruction shortens the interval window and reduces radiation exposure time. This enhancement alone reduces radiation dose by 21 percent over the previous software, as the more efficient imaging lowers the radiation exposure to the patient.
  • Real Time Beat Control calculates the running real time average of the heart rate to precisely predict the next heart beat for a more accurately timed scan. Important for patients with arrhythmia or unstable heart rates, Real Time Beat Control ensures better accuracy and improves image quality while reducing repetitive exams.
  • Optimized timing of SUREStart can determine contrast uptake time for a more accurate image. The upgraded SUREStart makes the transition from bolus chase to cardiac scanning virtually seamless. This feature creates better contrast timing, improves image quality and lowers contrast dose.

These upgraded software features will improve upon the already robust ability of the Aquilion ONE and Aquilion Premium in providing highly accurate diagnoses for a variety of cardiac cases.

“Giving our customers the tools they need to conduct low-dose exams is a priority for Toshiba,” said Doug Ryan, vice president, Marketing and Strategic Development, Toshiba. “These software enhancements to the Aquilion ONE and Aquilion Premium will help the medical community reduce radiation to patients while also ensuring high-quality images to enhance diagnostic confidence.”

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »